These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 26526901)
1. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Jia JB; Houshyar R; Verma S; Uchio E; Lall C Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901 [TBL] [Abstract][Full Text] [Related]
2. Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology. Grivas N; Hinnen K; de Jong J; Heemsbergen W; Moonen L; Witteveen T; van der Poel H; Heijmink S Eur J Radiol; 2018 Jan; 98():107-112. PubMed ID: 29279147 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience. Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792 [TBL] [Abstract][Full Text] [Related]
4. 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. Rosenkrantz AB; Mussi TC; Borofsky MS; Scionti SS; Grasso M; Taneja SS Urol Oncol; 2013 Nov; 31(8):1430-5. PubMed ID: 22464245 [TBL] [Abstract][Full Text] [Related]
5. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686 [TBL] [Abstract][Full Text] [Related]
6. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842 [TBL] [Abstract][Full Text] [Related]
7. Ruling out clinically significant prostate cancer with negative multi-parametric MRI. An JY; Sidana A; Holzman SA; Baiocco JA; Mehralivand S; Choyke PL; Wood BJ; Turkbey B; Pinto PA Int Urol Nephrol; 2018 Jan; 50(1):7-12. PubMed ID: 29143253 [TBL] [Abstract][Full Text] [Related]
8. Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service. Tsai WC; Field L; Stewart S; Schultz M J Med Imaging Radiat Oncol; 2020 Jun; 64(3):379-384. PubMed ID: 32243728 [TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
10. Prostate magnetic resonance imaging: The truth lies in the eye of the beholder. Riney JC; Sarwani NE; Siddique S; Raman JD Urol Oncol; 2018 Apr; 36(4):159.e1-159.e5. PubMed ID: 29336979 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer. Huang G; Lebovic G; Vlachou PA AJR Am J Roentgenol; 2019 Oct; 213(4):831-835. PubMed ID: 31216196 [No Abstract] [Full Text] [Related]
12. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT. Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519 [TBL] [Abstract][Full Text] [Related]
13. Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging. Al-Bayati M; Grueneisen J; Lütje S; Sawicki LM; Suntharalingam S; Tschirdewahn S; Forsting M; Rübben H; Herrmann K; Umutlu L; Wetter A Urol Int; 2018; 100(2):164-171. PubMed ID: 29393268 [TBL] [Abstract][Full Text] [Related]
14. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level]. Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587 [TBL] [Abstract][Full Text] [Related]
15. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool. Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025 [TBL] [Abstract][Full Text] [Related]
16. Role of multi-parametric (mp) MRI in prostate cancer. Nazim SM; Ather MH; Salam B J Pak Med Assoc; 2018 Jan; 68(1):98-104. PubMed ID: 29371727 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores. Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218 [TBL] [Abstract][Full Text] [Related]
18. Multi-parametric MRI findings of transitional zone prostate cancers: correlation with 3-dimensional transperineal mapping biopsy. Pokharel SS; Patel NU; Garg K; La Rosa FG; Arangua P; Jones C; Crawford ED Abdom Imaging; 2015 Jan; 40(1):143-50. PubMed ID: 25038718 [TBL] [Abstract][Full Text] [Related]
19. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma. Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]